Meloxicam Biogaran

Meloxicam, the active ingredient in Meloxicam Biogaran, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for systemic use. It is prescribed to relieve pain and reduce inflammation in adults with musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute painful conditions.

GNH USA supplies Meloxicam Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch, ensuring reliable supply chains across regions.

Meloxicam is used to manage inflammatory and painful conditions within the musculoskeletal disease spectrum.

- Osteoarthritis: reduces joint pain and improves functional ability. - Rheumatoid arthritis: alleviates inflammation and slows joint damage progression. - Ankylosing spondylitis: decreases spinal stiffness and associated pain. - Acute pain: provides short‑term relief of moderate to severe pain.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dyspepsia or stomach upset - Headache or dizziness - Peripheral edema - Skin rash or pruritus - Mild elevation of liver enzymes

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Cardiovascular events such as myocardial infarction - Severe liver injury or hepatitis - Acute renal failure or worsening of chronic kidney disease - Anaphylactic or severe hypersensitivity reactions - Stevens‑Johnson syndrome or toxic epidermal necrolysis

When prescribing meloxicam, clinicians should consider several precautionary measures to minimize risk.

- Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor cardiovascular status: use the lowest effective dose in patients with heart disease. - Evaluate renal and hepatic function: check baseline labs and adjust if impairment is present. - Avoid concomitant use with other NSAIDs or anticoagulants: increased bleeding risk. - Store at ambient temperature: keep in the original container, protect from moisture.

Meloxicam can interact with other medicines, requiring careful review before co‑administration.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of bleeding. - Other NSAIDs: additive gastrointestinal toxicity. - Lithium: increased lithium serum concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal function. - Methotrexate: enhanced methotrexate toxicity. - Selective serotonin reuptake inhibitors (SSRIs): increased bleeding tendency.